Grace Colón
Grace Colón is a biotechnology executive with over 25 years of experience in various sectors including biopharma, genomics, diagnostics, health care, digital health, synthetic biology, and industrial biotechnology.
She has a strong business and technical background, proven leadership skills, and is experienced in both for-profit and non-profit board director roles. Grace is recognized as a serial entrepreneur, invited speaker, lecturer, and mentor to startups and entrepreneurs, particularly focusing on women and underrepresented minorities in board positions.
Currently, Grace serves on the boards of Voyager Therapeutics, Bloom Science, and Emm. She is also actively involved in organizations such as MIT, the Biotechnology Innovation Organization (BIO), and various other biotech and healthcare companies.
Her domain expertise includes therapeutics, medical devices, genomics, proteomics, microbiome, diagnostics, digital health, synthetic biology, and greentech. Grace's functional expertise spans strategic planning, project management, marketing, business development, venture capital, fundraising, entrepreneurship, diversity and inclusion.
Beyond her professional endeavors, Grace hails from San Juan, Puerto Rico, and is a mother of three. She leads an active lifestyle enjoying activities like running, yoga, weight lifting, SCUBA diving, paddle boarding, and has interests in science fiction, singing, musical theatre, sea glass collecting, and juggling.
Educationally, Grace studied Chemical Engineering at various institutions including MIT, University of Pennsylvania, and Université de Technologie de Compiègne. She actively contributes to multiple organizations and has held key positions in diverse companies and advisory roles throughout her career.
